SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

InnoCare Reports First Patient Dosed in China Trial of ICP-B161

Valid market news retained in the public archive without immediate LiveCast distribution.

Related stories